Skip to content

Drug interactions

Deferiprone + Sulphasalazine

Severity: Major

Deferiprone and Sulphasalazine: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs can cause neutropenia and agranulocytosis. Combined use raises the risk of serious infection from bone marrow suppression.

What this interaction means in plain words

Deferiprone and Sulphasalazine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Deferiprone belongs to Miscellaneous; Sulphasalazine belongs to Gastrointestinal Tract.

Evidence level: Moderate

Why it happens

Additive myelosuppressive toxicity affecting neutrophils.

What to do

Avoid combining where an alternative exists. If unavoidable, check absolute neutrophil counts more frequently and stop therapy promptly if neutropenia develops.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Deferiprone and Sulphasalazine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Deferiprone with Sulphasalazine?

MediHelp rates the interaction as major. Deferiprone and Sulphasalazine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both drugs can cause neutropenia and agranulocytosis. Combined use raises the risk of serious infection from bone marrow suppression.

How serious is the interaction between Deferiprone and Sulphasalazine?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid combining where an alternative exists. If unavoidable, check absolute neutrophil counts more frequently and stop therapy promptly if neutropenia develops.

What other medicines interact with Sulphasalazine?

MediHelp also lists interactions of Sulphasalazine with, for example, Pexidartinib, Sepiapterin, Acalabrutinib. The full list is on the Sulphasalazine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in